Will Kering’s $4bn beauty divestment to L’Oréal revive Gucci’s fortunes and reshape luxury competition?

Why is Gucci-owner Kering selling its beauty division to L’Oréal now?

French luxury group Kering SA (EPA: PRTP) is reportedly in advanced negotiations to sell its beauty division to L’Oréal SA (EPA: OR) in a potential $4 billion deal. The transaction would include the fragrance brand Creed, which Kering acquired in 2023, along with beauty rights tied to luxury fashion houses Bottega Veneta, Balenciaga, and Alexander McQueen. Sources suggest the agreement could be announced as soon as next week, marking a dramatic reshaping of Kering’s corporate portfolio.

For Kering, this move represents both a financial reset and a philosophical pivot. The Paris-based group has faced pressure to revive its flagship brand Gucci, which has been struggling to regain momentum amid slowing global luxury demand and shifting consumer tastes in the United States and China. By offloading its beauty arm, Kering appears to be narrowing its focus to high-margin fashion and leather goods, while freeing up capital for reinvestment and debt reduction.

For L’Oréal, already the world’s largest beauty company, the acquisition could fortify its dominance in the luxury segment by adding Creed’s premium fragrance cachet and giving it access to some of the most recognisable fashion labels on the planet.

How did Kering’s beauty ambitions evolve, and what led to this reversal?

Kering’s beauty story began in 2023 when it launched Kering Beauté, an internal division intended to reclaim control over fragrance and cosmetic licensing. Historically, brands like Gucci Beauty and Yves Saint Laurent Beauté had operated through third-party agreements, primarily with Coty Inc. and L’Oréal. The new in-house unit was a bold move meant to mimic LVMH’s success with Christian Dior Parfums and consolidate brand equity within Kering’s portfolio.

However, scaling a beauty business from scratch proved far more challenging than anticipated. Despite acquiring Creed—a century-old niche perfume house founded in London and prized for its cult following—the division generated only about €323 million in 2024 revenue, a fraction of Kering’s total €17.2 billion. The group’s overall performance faltered, with recurring operating income plunging by 46 % and Gucci’s annual revenue sliding 23 % to €7.65 billion.

Mounting debt, estimated at €10.5 billion by the end of 2024, further limited flexibility. Analysts believe the company’s leadership change—Luca de Meo taking over as CEO in mid-2025—accelerated the strategic review that ultimately led to the divestment plan. Insiders describe the sale as part of a “reset year,” echoing similar repositioning efforts seen at peers like Richemont SA and Burberry Group plc.

What does L’Oréal gain from the acquisition, and why now?

For L’Oréal SA, whose 2024 sales crossed €43 billion, the acquisition offers both tactical and symbolic advantages. Creed would become a crown jewel in L’Oréal’s Luxe division, joining brands such as Lancôme, Yves Saint Laurent Beauté, and Armani Beauty. More importantly, it gives L’Oréal entry points into new licensing territories that could extend across skincare, cosmetics, and exclusive fragrance lines bearing the prestige of Balenciaga, Alexander McQueen, and Bottega Veneta.

L’Oréal’s leadership has long emphasised “premiumisation”—shifting the company’s focus toward the upper end of the market where margins are thicker and customer loyalty deeper. The Kering acquisition fits neatly into that strategy. It enhances the group’s exposure to affluent consumers, strengthens its European manufacturing footprint, and opens opportunities in Asia’s expanding luxury beauty markets.

Industry observers see it as a statement deal that reinforces L’Oréal’s leadership not just in mass and professional beauty, but in high-end fragrance and cosmetics—segments that continue to outpace broader consumer goods growth even amid global economic uncertainty.

How are investors reacting to Kering’s potential divestment?

Market sentiment surrounding Kering’s stock has been cautious but mildly optimistic. Shares rose modestly after reports of the talks surfaced, as investors interpreted the move as a pragmatic step toward simplifying operations and improving financial discipline. The luxury conglomerate’s market capitalisation, which had eroded sharply through 2024, could benefit from a one-time cash infusion if the deal closes near the expected $4 billion valuation.

Still, some analysts warn that the transaction might be seen as a “fire-sale” if the proceeds are not effectively redeployed. Much will depend on whether the sale price reflects fair value for Creed and the underlying beauty rights, and how Kering communicates its reinvestment strategy.

Institutional investors, particularly European asset managers, have been pressing Kering for clearer signals of recovery at Gucci and other fashion houses. While divestments can be healthy in a restructuring cycle, long-term sentiment will hinge on operational turnaround, not just balance-sheet management.

By contrast, L’Oréal’s stock is widely expected to benefit from renewed growth potential. Investors have rewarded the company’s disciplined acquisition history—ranging from Mugler and Azzaro in 2020 to Youth to the People in 2021—viewing each deal as strategically accretive rather than speculative.

What could this deal mean for the global luxury and beauty landscape?

Beyond the boardroom arithmetic, this potential acquisition reshapes the luxury-beauty landscape. Over the past decade, fragrance and cosmetics have emerged as the most accessible gateways into luxury consumption, providing brands with scalable revenue while cultivating aspirational customers. The move reinforces a growing divide between conglomerates that own integrated beauty operations (like LVMH and L’Oréal) and those that rely on licensing or external partnerships.

If completed, the deal would return Kering’s beauty rights for multiple brands to the very company that previously licensed them—creating a full-circle moment in luxury history. It also signals a broader trend: fashion groups that fail to achieve critical mass in beauty are increasingly offloading these units to specialist giants better equipped to manage manufacturing, regulation, and global distribution.

For L’Oréal, adding Creed and Kering’s fashion-house beauty rights deepens its grip on the high-margin perfume segment and ensures competitive distance from rivals such as Estée Lauder Companies Inc. and Shiseido Co. Ltd. It’s also likely to drive innovation across L’Oréal’s prestige and couture divisions, potentially setting up new capsule fragrance lines under each house’s creative direction.

What are the risks, and what questions remain unanswered?

The deal remains unconfirmed, and several uncertainties hover. The final valuation could shift depending on debt adjustments and licensing rights. Regulatory review, especially in Europe’s competitive fragrance market, may impose conditions on exclusivity or intellectual-property transfers.

For Kering, the key risk lies in execution—how effectively it reinvests proceeds to revitalise Gucci, Saint Laurent, and Balenciaga. Failure to translate the sale into long-term brand growth could undermine investor confidence.

For L’Oréal, integration risk looms large. Aligning a niche fragrance business with global luxury distribution requires careful brand management to preserve exclusivity while scaling reach. Creed’s heritage audience expects craftsmanship and scarcity—traits that can be diluted if mass-marketed.

What’s next for both companies as 2025 winds down?

Analysts believe Kering will focus on rebuilding its core fashion portfolio, particularly through high-end product segmentation and more controlled distribution channels. With new creative directors at both Gucci and Balenciaga, the company may use 2026 as a “re-acceleration” year—potentially supported by capital freed from the L’Oréal transaction.

L’Oréal, meanwhile, could leverage the deal to deepen its partnerships with luxury retailers and duty-free operators. The integration of Creed could set a precedent for further acquisitions in the niche-luxury fragrance segment, where valuations remain attractive and consumer loyalty resilient. Some analysts even speculate that this move could inspire other fashion houses still dependent on licensing—such as Prada or Valentino—to reconsider their beauty strategies.

What are the most important takeaways from Kering’s $4 billion beauty deal with L’Oréal?

• Kering SA is reportedly close to completing a $4 billion divestment of its beauty division—including Creed—to L’Oréal SA, marking one of the biggest luxury-beauty transactions of 2025.

• The sale represents Kering’s strategic retreat from beauty, enabling sharper focus on fashion and leather goods while strengthening its balance sheet and liquidity position.

• For L’Oréal, the acquisition adds premium assets like Creed and potential licensing access to Balenciaga, Alexander McQueen, and Bottega Veneta, reinforcing its dominance in luxury fragrance and cosmetics.

• Investor sentiment toward Kering stock has turned cautiously optimistic, hinging on how efficiently the company redeploys proceeds into its core brands and whether Gucci’s turnaround gains traction.

• The move underscores an accelerating industry consolidation trend, as fashion conglomerates offload beauty operations to specialised giants better equipped for global scale.

• Execution risks persist on both sides: Kering must deliver operational recovery, while L’Oréal faces the challenge of integrating Creed without diluting its exclusivity.

• If completed, the deal could reshape Europe’s luxury-beauty power map, setting new benchmarks for how fashion and cosmetics giants collaborate and compete.